Drug – bio-affecting and body treating compositions – Plural fermentates of different origin
Patent
1984-02-27
1985-03-05
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Plural fermentates of different origin
2602452R, 2602452L, 514210, C07D49900, A61K 31425
Patent
active
045030405
ABSTRACT:
Beta-lactamase inhibitors which are aminoacid esters of 6-alpha- and 6-beta-(hydroxymethyl)pencillanic acid 1,1-dioxides; pharmaceutically-acceptable salts thereof; conventional esters thereof which are hydrolyzable in vivo; bis-methanediol esters thereof; or mixed methanediol esters with said beta-lactamase inhibitors and sulbactam. Pharmaceutical compositions comprising said beta-lactamase inhibitors and a conventional beta-lactam antibiotic, said compositions useful in the treatment of bacterial infections. Compounds useful as intermediates in the synthesis of said beta-lactamase inhibitors. Antibacterial mixed bis-methanediol esters of said aminoacyloxymethyl penicillanic acid 1,1-dioxides and ampicillin or amoxicillin, also useful in the treatment of bacterial infections; and intermediates therefor.
REFERENCES:
patent: 4287181 (1981-09-01), Kellogg
patent: 4342768 (1982-08-01), Kellogg
Blackwood Robert K.
Frost Albert E.
Knuth Charles J.
Pfizer Inc.
Rizzo Nicholas S.
LandOfFree
6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1734041